Respiratory Pathogen Coinfection During Intersecting COVID-19 and Influenza Epidemics
Pathogens · 2024
DOI: 10.3390/pathogens13121113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Lina Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen Center for Disease Control and Prevention, 681 Shengguang Road, Xiamen 361021, China. Hauptthemen laut MEDLINE: COVID-19, Coinfection, Influenza, Human, SARS-CoV-2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Nova Program, the Key Specialty of Clinical Medicine of Xiamen, China, Fujian Province Health Science and Technology Project.
Abstract (Originalsprache)
Respiratory pathogen coinfections pose significant challenges to global public health, particularly regarding the intersecting epidemics of COVID-19 and influenza. This study investigated the incidences of respiratory infectious pathogens in this unique context. We collected throat swab samples from 308 patients with a fever from outpatient and emergency departments at sentinel surveillance hospitals in Xiamen, southeast of China, between April and May 2023, testing for SARS-CoV-2 and 26 other respiratory pathogens. The coinfection rate of the XBB SARS-CoV-2 variant with other respiratory pathogens was higher than that observed during the Alpha and Delta phases. Among patients with influenza, bacterial coinfections were more prevalent. Only 0.65% (2/308) of the patients were concurrently infected with both COVID-19 and influenza. Age-stratified analysis showed a clear pattern, with a higher incidence of coinfections in children under 18 years of age. These findings highlight the need for the timely detection of respiratory pathogen coinfections and for the implementation of appropriate interventions, crucial for reducing disease burden during intersecting respiratory epidemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Xiamen Center for Disease Control and Prevention, 681 Shengguang Road, Xiamen 361021, China.
- National Key Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, 20 Dongdajie Road, Beijing 100071, China.
ORCID-Profile: Zhongyi Wang
Förderung
- Beijing Nova Program
- the Key Specialty of Clinical Medicine of Xiamen, China
- Fujian Province Health Science and Technology Project
Zitieren
APA
Jiang, L., Jin, Y., Li, J., Zhang, R., Zhang, Y., Cheng, H., Lu, B., Zheng, J., Li, L., & Wang, Z. (2024). Respiratory Pathogen Coinfection During Intersecting COVID-19 and Influenza Epidemics. Pathogens. https://doi.org/10.3390/pathogens13121113
Vancouver
Jiang L, Jin Y, Li J, Zhang R, Zhang Y, Cheng H, et al. Respiratory Pathogen Coinfection During Intersecting COVID-19 and Influenza Epidemics. Pathogens. 2024. doi:10.3390/pathogens13121113
BibTeX
@article{Jiang2024,
author = {Jiang, Lina and Jin, Yifei and Li, Jingjing and Zhang, Rongqiu and Zhang, Yidun and Cheng, Hongliang and Lu, Bing and Zheng, Jing and Li, Li and Wang, Zhongyi},
title = {Respiratory Pathogen Coinfection During Intersecting COVID-19 and Influenza Epidemics},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13121113}
}
EUVIMED